Santé log

Best Wegovy Alternative for 2026? FDA Approves Oral Semaglutide as Patients Evaluate Compounded Telehealth Access — Direct Meds Examined as Verification Case Study

The FDA's December 22, 2025 approval expanded GLP-1 access beyond injectable formulations by adding an oral semaglutide option for chronic weight management, based on FDA-reviewed labeling and ...
Santé log

Best Wegovy Pricing for 2026: Industry Analysis of FDA-Approved Oral and Injectable Cost Pathways as Telehealth Access Expands

Manufacturer and platform disclosures indicate oral Wegovy cash-pay pricing beginning at published introductory levels, depending on dose and access pathway, with broader availability expected in ...
Santé log

Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.
Santé log

Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...
Santé log

Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Adaptive Biotechnologies’ management is scheduled to present on Monday, January 12, 2026, at 4:30 p.m. Pacific Time / 7:30 p.m. Eastern Time. Interested parties may access a live and archived webcast ...
Santé log

Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
Santé log

AIM ImmunoTech Announces Stock Dividend

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share ...
Santé log

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Event: 44th Annual J.P. Morgan Healthcare Conference Date: Monday, January 12, 2026 Time: 9:00 am PST / 12:00 pm EST A live and archived webcast of the presentation will be available in the "Investor ...
Santé log

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ...
Santé log

Profound Medical Corp. Announces Closing of Private Placement

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...
Santé log

INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts ...
Santé log

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are ...